A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19
Public ClinicalTrials.gov record NCT04540185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Polio Vaccine and NA-831 for Prophylaxis and Treatment of Early Onset of Covid-19
Study identification
- NCT ID
- NCT04540185
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Biomed Industries, Inc.
- Industry
- Enrollment
- 3,600 participants
Conditions and interventions
Interventions
- Biological: oral polio vaccine Biological
- Combination of oral polio vaccine and NA-831 Combination Product
- Comparable Placebo Biological
- Comparable Placebo of Oral Polio Vaccine and Placebo of drug Combination Product
- Comparable Placebo of drug Drug
- NA-831 Drug
Biological · Combination Product · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2020
- Primary completion
- Oct 31, 2022
- Completion
- Dec 30, 2022
- Last update posted
- Sep 8, 2020
2020 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 3
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coronavirus Research Institute- Testing Site | Los Angeles | California | 90095 | — |
| Coronavirus Research Institute | Orange | California | 92868 | — |
| Coronavirus Research Institute-Testing Site | Palo Alto | California | 94304 | — |
| Coronavirus Research Testing Site | San Francisco | California | 94110 | — |
| Coronavirus Research Institute-Testing Site | Sunnyvale | California | 94086 | — |
| Coronavirus Research Institute | Sunnyvale | California | 94086 | — |
| Coronavirus Research Institute-Testing Site | Naperville | Illinois | 60540 | — |
| Coronavirus Research Institute-Testing Site- | The Bronx | New York | 10467 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04540185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2020 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04540185 live on ClinicalTrials.gov.